Tony McGinn presents a high-level overview of the state of parent training evidence. His blog draws on over 30 systematic reviews with meta-analyses, to bring you a handy summary of what works.
[read the full story...]
Andrew Jones summarises a recent Canadian cohort study, which explores the extent of substance misuse and addictive disorders among adults with intellectual and developmental disabilities.
[read the full story...]
Joff Jones summarises a meta-analysis of neurofeedback for ADHD in children, which concludes that current evidence is insufficient to recommend neurofeedback as a treatment for this group.
[read the full story...]
Samuele Cortese considers the findings of a recent nationwide self controlled case series study of the cardiovascular safety of methylphenidate use in children and young people with ADHD.
[read the full story...]
Marcus Munafo considers the implications of a recent Swedish population study, which explores patterns of non-random mating within and across 11 major psychiatric disorders.
[read the full story...]
Samuele Cortese publishes his debut Mental Elf blog on a meta-analysis of n-of-1 trials, which shows that amphetamine derivatives and methylphenidate are superior to placebo, in the short term, for paediatric ADHD.
[read the full story...]
Alan Underwood highlights a new meta-analysis, which suggests that people with mental health problems can benefit if they are prompted to form if-then plans, which specify when, where and how they will achieve their goals.
[read the full story...]
John Baker presents a systematic review of preferences for medication-associated outcomes in mental disorders, which concludes that we just don’t know what value mental health service users place on the different outcomes that come from taking psychiatric medication.
[read the full story...]
Chris Hollis appraises a recent Cochrane systematic review, which casts doubt over the quality of trial evidence and the clinical effectiveness of Methylphenidate for ADHD.
[read the full story...]
John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.
[read the full story...]
